SKI Market

Indian Indices

Sensex

85,188.60 -32.00
( -0.04%)

Global Indices

Nasdaq

48,084.29 -303.78
(-0.63%)

Dow Jones

6,866.50 -50.74
(-0.73%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.84 -0.06
(-0.06%)

EUR-INR

105.67 -0.12
(-0.11%)

GBP-INR

121.20 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

41.37

817.04

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.22

Back

Remedium Lifecare reports standalone net loss of Rs 0.37 crore in the June 2025 quarter

Aug 05,2025

Net loss of Remedium Lifecare reported to Rs 0.37 crore in the quarter ended June 2025 as against net profit of Rs 1.64 crore during the previous quarter ended June 2024. Sales declined 76.36% to Rs 18.37 crore in the quarter ended June 2025 as against Rs 77.70 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	18.37	77.70	-76
OPM %	-22.92	0.50	-
PBDT	-0.37	2.28	PL
PBT	-0.37	2.27	PL
NP	-0.37	1.64	PL

85,188.60 -32.00 ( -0.04%)

48,084.29 -303.78 (-0.63%)

6,866.50 -50.74 (-0.73%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.84 -0.06 (-0.06%)

105.67 -0.12 (-0.11%)

121.20 -0.12 (-0.10%)

0.58 0.00 (-0.05%)